Genomic Profiling

Genomic Profiling

Genomic Profiling analyzes tumor DNA/RNA patterns to identify actionable targets and inform precision treatment strategies.

What is Genomic Profiling?

Genomic profiling looks for genetic changes and molecular signals that may influence:

  • targeted therapy options
  • eligibility for certain clinical trials
  • risk markers that help guide planning

It’s like identifying which “wires” are crossed in the tumor’s biology so treatment can be more precise.

Why DNA/RNA quality matters

Advanced profiling often depends on the quality of the tumor material. That’s why tissue handling and preservation can matter—especially if you’re trying to preserve the option for deeper analysis later.

Where genomics fits in your timeline
  • Before treatment: establish a baseline and uncover potential targets
  • After changes in disease: compare evolution and adapt strategy
  • Before trial matching: confirm whether required markers may be present
Who should consider genomic profiling?
  • Patients who want to explore precision oncology paths
  • Patients facing complex decisions or uncertain next steps
  • Patients who want trial readiness and more personalized direction
Genomic Profiling FAQs
Will genomics tell me the perfect treatment?

Not always. It can uncover targets and clues—but decisions still require clinical context.

Not always. Tumors can evolve. Some patients benefit from repeat analysis over time.

Genomic Profiling

Genomic Profiling

Genomic Profiling analyzes tumor DNA/RNA patterns to identify actionable targets and inform precision treatment strategies.

What is Genomic Profiling?

Genomic profiling looks for genetic changes and molecular signals that may influence:

  • targeted therapy options
  • eligibility for certain clinical trials
  • risk markers that help guide planning

Analogy:

Instead of trying keys in the lock (your body), you test the keys on a copy of the lock first.

Why DNA/RNA quality matters

Advanced profiling often depends on the quality of the tumor material. That’s why tissue handling and preservation can matter—especially if you’re trying to preserve the option for deeper analysis later.

Where genomics fits in your timeline

  • Before treatment: establish a baseline and uncover potential targets
  • After changes in disease: compare evolution and adapt strategy
  • Before trial matching: confirm whether required markers may be present

Who should consider genomic profiling?

  • Patients who want to explore precision oncology paths
  • Patients facing complex decisions or uncertain next steps
  • Patients who want trial readiness and more personalized direction
Will genomics tell me the perfect treatment?

Not always. It can uncover targets and clues—but decisions still require clinical context.

Is genomics “one and done”?

Not always. Tumors can evolve. Some patients benefit from repeat analysis over time.